Condition
Monoclonal Gammopathies clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Monoclonal Gammopathies clinical trials that are recruiting, at sites in 2 countries (most in Italy (1), China (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
How N-glycosylation of light chains affects AL amyloidosis diagnosis and treatment
This project will test whether a sugar modification called N-glycosylation on immunoglobulin light chains helps cause disease or changes how AL amyloidosis and related monoclonal gammopathies behave in adults.
-
Using mass spectrometry to monitor multiple myeloma
This study is testing a new way to use mass spectrometry to see if it can help doctors better detect and monitor multiple myeloma in patients by analyzing their blood samples.
Related topics
Quick answers
How many Monoclonal Gammopathies clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.